• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[苯丙氨酸1]-NC-(1-13)-NH2(一种纯的选择性孤啡肽/孤啡肽FQ受体拮抗剂)的构效关系

Structure-activity relationship of [Nphe1]-NC-(1-13)-NH2, a pure and selective nociceptin/orphanin FQ receptor antagonist.

作者信息

Guerrini R, Calo' G, Bigoni R, Rizzi D, Regoli D, Salvadori S

机构信息

Department of Pharmaceutical Sciences and Biotechnology Center, Ferrara, Italy.

出版信息

J Pept Res. 2001 Mar;57(3):215-22. doi: 10.1111/j.1399-3011.2001.00820.x.

DOI:10.1111/j.1399-3011.2001.00820.x
PMID:11298922
Abstract

A series of analogs of the ORL1 receptor antagonist [Nphe1]-NC(1-13)-NH2 was prepared and tested for agonistic and antagonistic activities in the mouse vas deferens, a preparation that shows high sensitivity to nociceptin and related peptides. The purpose of this study was to determine the role of the aromatic residue at the N-terminal for antagonism and eventually identify compounds with improved potency. Results indicated that all 23 compounds are inactive as agonists, and the antagonistic potency of the initial template [Nphe1]-NC(1-13)-NH2 is high (pKB 6.43) compared with those of all other compounds except [(S)(betaMe)Nphe1]NC(1-13)-NH2 (pK(B) 6.48). The other 22 compounds can be divided into two groups: 10 show antagonistic potencies (pK(B)) ranging from 5.30 to 5.86, whereas the other 12 compounds are inactive. This study clearly shows that the aromatic ring of Nphe is very critical for the interaction with the ORL1 receptor and can not be enlarged or sterically modified without significant loss of antagonistic potency.

摘要

制备了一系列ORL1受体拮抗剂[Nphe1]-NC(1-13)-NH2的类似物,并在小鼠输精管中测试其激动和拮抗活性,该制剂对孤啡肽及相关肽表现出高敏感性。本研究的目的是确定N端芳香族氨基酸残基在拮抗作用中的作用,并最终鉴定出效力提高的化合物。结果表明,所有23种化合物均无激动剂活性,初始模板[Nphe1]-NC(1-13)-NH2的拮抗效力较高(pKB 6.43),与除[(S)(βMe)Nphe1]NC(1-13)-NH2(pK(B) 6.48)之外的所有其他化合物相比。其他22种化合物可分为两组:10种表现出5.30至5.86的拮抗效力(pK(B)),而其他12种化合物无活性。本研究清楚地表明,Nphe的芳香环对于与ORL1受体的相互作用非常关键,并且在不显著丧失拮抗效力的情况下不能扩大或进行空间修饰。

相似文献

1
Structure-activity relationship of [Nphe1]-NC-(1-13)-NH2, a pure and selective nociceptin/orphanin FQ receptor antagonist.[苯丙氨酸1]-NC-(1-13)-NH2(一种纯的选择性孤啡肽/孤啡肽FQ受体拮抗剂)的构效关系
J Pept Res. 2001 Mar;57(3):215-22. doi: 10.1111/j.1399-3011.2001.00820.x.
2
Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.关于痛敏肽相关肽的进一步研究:发现一种对痛敏肽受体具有拮抗活性的新化学模板。
J Med Chem. 2000 Jul 27;43(15):2805-13. doi: 10.1021/jm990075h.
3
Pharmacological characterization of nociceptin receptor: an in vitro study.
Can J Physiol Pharmacol. 1997 Jun;75(6):713-8.
4
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist.痛敏肽(1-13)-NH2 N端四肽的构效关系研究及痛敏肽受体拮抗剂的发现
J Med Chem. 1998 Aug 27;41(18):3360-6. doi: 10.1021/jm970805q.
5
Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor.新型强效激动剂[(pF)苯丙氨酸4、Aib7、Aib11、精氨酸14、赖氨酸15]孤啡肽-酰胺和孤啡肽/孤啡肽FQ受体拮抗剂[N-苯丙氨酸1、(pF)苯丙氨酸4、Aib7、Aib11、精氨酸14、赖氨酸15]孤啡肽-酰胺
Regul Pept. 2006 May 15;134(2-3):75-81. doi: 10.1016/j.regpep.2006.01.003. Epub 2006 Mar 6.
6
Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.环阿片肽/孤啡肽FQ类似物c[Cys10,14]N/OFQ(1 - 14)NH2和c[Nphe1,Cys10,14]N/OFQ(1 - 14)NH2的药理学特征
Naunyn Schmiedebergs Arch Pharmacol. 2003 Dec;368(6):528-37. doi: 10.1007/s00210-003-0821-5. Epub 2003 Nov 4.
7
Antagonistic effects of [Nphe1]nociceptin(1-13)NH2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese hamster ovary cells stably expressing the recombinant human nociceptin receptor.[Nphe1] 孤啡肽(1-13)NH2 对稳定表达重组人孤啡肽受体的中国仓鼠卵巢细胞中孤啡肽受体介导的 cAMP 生成抑制作用的拮抗效应
Neurosci Lett. 2000 Jan 7;278(1-2):109-12. doi: 10.1016/s0304-3940(99)00915-5.
8
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptor.孤啡肽(1-13)-NH₂的苯丙氨酸(4)残基的构效关系研究:孤啡肽/孤啡肽FQ受体高效激动剂的鉴定
J Med Chem. 2001 Nov 8;44(23):3956-64. doi: 10.1021/jm010221v.
9
Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues.Ro 64-6198对孤啡肽敏感的离体组织的作用。
Naunyn Schmiedebergs Arch Pharmacol. 2001 May;363(5):551-5. doi: 10.1007/s002100100399.
10
Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide.痛敏肽受体的地址和信息序列:痛敏肽-(1-13)-肽酰胺的构效关系研究
J Med Chem. 1997 Jun 6;40(12):1789-93. doi: 10.1021/jm970011b.

引用本文的文献

1
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH.阿片胜肽/孤啡肽受体的偏性激动作用:N/OFQ(1-13)-NH 的结构活性研究。
J Med Chem. 2020 Oct 8;63(19):10782-10795. doi: 10.1021/acs.jmedchem.9b02057. Epub 2020 Sep 24.
2
Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors.新型放射性配体[(3)H]UFP-101与重组人源及天然大鼠孤啡肽/孤啡肽FQ受体的结合
Naunyn Schmiedebergs Arch Pharmacol. 2008 Dec;378(6):553-61. doi: 10.1007/s00210-008-0350-3. Epub 2008 Sep 21.
3
UFP-101, a high affinity antagonist for the nociceptin/orphanin FQ receptor: radioligand and GTPgamma(35)S binding studies.
UFP-101,一种强啡肽/孤啡肽FQ受体的高亲和力拮抗剂:放射性配体和GTPγ(35)S结合研究。
Naunyn Schmiedebergs Arch Pharmacol. 2003 Feb;367(2):183-7. doi: 10.1007/s00210-002-0661-8. Epub 2003 Jan 15.